Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population PK/PD study of meropenem in adults with severe pulmonary infection
ChiCTR1900020672Phase 4Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meropenem in pulmonary infection, sponsored by The Second Xiangya Hospital. Primary endpoint: Blood concentration. Started Jan 2019; status: recruiting.
02
Drugs
meropenem
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ChiCTR1900020672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020672.